Civil Court (Undecided Case No. 2374/2562 and Decided Case No. 6984/2563). The Court of Appeal’s decision is final.SEC Secretary-General Ruenvadee Suwanmongkol said: “This is a case of unfair treatment
Development (OECD), which cover six areas as follows: 1. Enforcement and CG framework 2. Rights of shareholders 3. Equitable treatment of shareholders 4. Roles of stakeholders in CG 5. Disclosure and
Development (OECD), which cover six areas as follows: 1. Enforcement and CG framework 2. Rights of shareholders 3. Equitable treatment of shareholders 4. Roles of stakeholders in CG 5. Disclosure and
treatment income of chronic diseases from Social Security Office. Subsequently, Mr. Kumpol Plussind commit offense in using Mr. Krit Plussind's and Miss Kullapa Plussind's securities trading
overall risk management 1) Climate-related metrics 2) Scope 1, 2, 3 GHG Emissions 3) Climate-related targets The organization’s governance around climate-related risks and opportunities. The actual and
Microsoft Word - MD&A_E Q1_2561_จัดใหม่ Management Discussion and Analysis: MD&A 1. Company Situation Revenue from the waste treatment business for Q1/2018 slightly increased compare to Q1/2017. The
Company and its subsidiary for Quarter 3 of 2019 ending on 30 September 2019 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical
subsidiary for Quarter 1 of 2020 ending on 31 March 2020 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical treatment for the 1st
sale of convertible bonds at lower market price” means an offer for sale of newly issued convertible bonds of which the offered price combined with the exercise price is within the scope of an offering
: ............................................................................................................................... 2. Starting Date of Operation: ............................................................................................................ 3. Details of the Company: 3.1 Scope of operation of the